Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed May 5, 2023
- Accession no.
- 0001209191-23-027830
- Filed
- May 5, 2023
- Trade date
- Jan 5-May 3, 2023
- Filing delay
- 120 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 17 non-derivative transactions and 8 derivative transactions. Open-market sales total $278.3K. It was filed 120 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Class A Common Stock | CConversionAcquired | +3,000 | $0.00 | $0 | 966,710 | Direct | |
| Jan 5, 2023 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 963,710 | Direct | |
| Feb 2, 2023 | Class A Common Stock | CConversionAcquired | +3,000 | $0.00 | $0 | 966,710 | Direct | |
| Feb 2, 2023 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 963,710 | Direct | |
| Mar 2, 2023 | Class A Common Stock | CConversionAcquired | +3,000 | $0.00 | $0 | 966,710 | Direct | |
| Mar 2, 2023 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 963,710 | Direct | |
| May 3, 2023 | Class A Common Stock | GGiftDisposed | −8,662 | $0.00 | $0 | 955,048 | Direct | |
| May 3, 2023 | Class A Common Stock | CConversionAcquired | +1,338 | $0.00 | $0 | 956,386 | Direct | |
| May 3, 2023 | Class A Common Stock | GGiftDisposed | −1,338 | $0.00 | $0 | 955,048 | Direct | |
| May 3, 2023 | Class A Common Stock | MOption exerciseAcquired | +31,250 | $2.48 | +$77,500 | 986,298 | Direct | |
| May 3, 2023 | Class A Common Stock | SSaleDisposed | −33,073 | $4.71F5 | −$155,773.83 | 953,225 | Direct | |
| May 3, 2023 | Class A Common Stock | CConversionAcquired | +4,000 | $0.00 | $0 | 4,000 | Indirect | |
| May 3, 2023 | Class A Common Stock | SSaleDisposed | −4,000 | $4.91F7 | −$19,640 | 0 | Indirect | |
| May 3, 2023 | Class A Common Stock | CConversionAcquired | +20,000 | $0.00 | $0 | 20,000 | Indirect | |
| May 3, 2023 | Class A Common Stock | SSaleDisposed | −20,000 | $4.90F7 | −$98,000 | 0 | Indirect | |
| May 3, 2023 | Class A Common Stock | CConversionAcquired | +1,000 | $0.00 | $0 | 1,000 | Indirect | |
| May 3, 2023 | Class A Common Stock | SSaleDisposed | −1,000 | $4.92F10 | −$4,920 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | Class A Common Stock | MOption exerciseDisposed | −31,250 | $0.00 | $0 | 625,000 | Direct | |
| Jan 5, 2023 | Class A Common Stock | CConversionDisposed | −3,000 | $0.00 | $0 | 6,558,834 | Direct | |
| Feb 2, 2023 | Class A Common Stock | CConversionDisposed | −3,000 | $0.00 | $0 | 6,555,834 | Direct | |
| Mar 2, 2023 | Class A Common Stock | CConversionDisposed | −3,000 | $0.00 | $0 | 6,552,834 | Direct | |
| May 3, 2023 | Class A Common Stock | CConversionDisposed | −1,338 | $0.00 | $0 | 6,551,496 | Direct | |
| May 3, 2023 | Class A Common Stock | CConversionDisposed | −4,000 | $0.00 | $0 | 531,000 | Indirect | |
| May 3, 2023 | Class A Common Stock | CConversionDisposed | −20,000 | $0.00 | $0 | 488,000 | Indirect | |
| May 3, 2023 | Class A Common Stock | CConversionDisposed | −1,000 | $0.00 | $0 | 122,875 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
This transaction was executed in multiple trades at prices ranging from $4.55 to $5.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $4.57 to $5.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 2 transactions in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $4.64 to $5.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.